Endocrine-disrupting chemicals and risk of diabetes: an evidence-based review P. Monica LindLars Lind Review Open access 09 May 2018 Pages: 1495 - 1502
Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies Guntram SchernthanerMarie Helene Schernthaner-Reiter Review Open access 07 February 2018 Pages: 1503 - 1516
Spouses, social networks and other upstream determinants of type 2 diabetes mellitus Joreintje D. MackenbachNicole R. den BraverJoline W. J. Beulens Commentary Open access 13 April 2018 Pages: 1517 - 1521
Empagliflozin in women with type 2 diabetes and cardiovascular disease – an analysis of EMPA-REG OUTCOME® Bernard ZinmanSilvio E. Inzucchion behalf of the EMPA-REG OUTCOME® investigators Short Communication 30 April 2018 Pages: 1522 - 1527
Community-based pre-pregnancy care programme improves pregnancy preparation in women with pregestational diabetes Jennifer M. YamamotoDeborah J. F. HughesHelen R. Murphy Article Open access 09 May 2018 Pages: 1528 - 1537
Persistence of abnormalities in white matter in children with type 1 diabetes Larry A. FoxTamara Hersheyfor the Diabetes Research in Children Network (DirecNet) Article 13 April 2018 Pages: 1538 - 1547
A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial Julia OttenAndreas StombyTommy Olsson Article Open access 26 April 2018 Pages: 1548 - 1559
Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial Miguel Ruiz-CanelaMarta Guasch-FerréMiguel A. Martínez-González Article 16 April 2018 Pages: 1560 - 1571
Spousal cardiometabolic risk factors and incidence of type 2 diabetes: a prospective analysis from the English Longitudinal Study of Ageing Jannie NielsenAdam HulmanDaniel R. Witte Article 08 March 2018 Pages: 1572 - 1580
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial Paul WelshNaomi RankinNaveed Sattar Article Open access 04 May 2018 Pages: 1581 - 1591
Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates Francesco ZaccardiNafeesa N. DhalwaniKamlesh Khunti Article Open access 01 May 2018 Pages: 1592 - 1602
Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand Mohanraj KrishnanTanya J. MajorTony R. Merriman Article 02 May 2018 Pages: 1603 - 1613
Patterns of differential gene expression in a cellular model of human islet development, and relationship to type 2 diabetes predisposition Marta Perez-AlcantaraChristian HonoréMartijn van de Bunt Article Open access 19 April 2018 Pages: 1614 - 1622
SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients Else M. BalkeSimke DemeesterFrans K. Gorus Article 20 April 2018 Pages: 1623 - 1632
A proinflammatory CD4+ T cell phenotype in gestational diabetes mellitus Angela SheuYixian ChanSue Mei Lau Article 24 April 2018 Pages: 1633 - 1643
Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12 Peter AchenbachMohammed I. Hawaon behalf of the Action LADA consortium Short Communication Open access 04 April 2018 Pages: 1644 - 1649
Abnormal islet sphingolipid metabolism in type 1 diabetes Laurits J. HolmLars KrogvoldKarsten Buschard Article Open access 18 April 2018 Pages: 1650 - 1661
Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models Gemma V. BrierleyKenneth SiddleRobert K. Semple Article Open access 27 April 2018 Pages: 1662 - 1675
The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes Joel T. DunnPratik ChoudharyStephanie A. Amiel Article Open access 12 May 2018 Pages: 1676 - 1687
Correction to: Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis Krishnarajah NirantharakumarNuredin MohammedParth Narendran Correction 25 April 2018 Pages: 1688 - 1689